Biotech Values

[RockRat]

What makes this different from most other drug copying, in which quality checks and assays to make sure at each step in the synthesis what you've got is what you wanted to get, is that most of those assays are in the public domain or are cheap and easy to license. In the copying and manufacture of complex mixtures like enoxaparin and copaxone, they are not. It might be hard to prove. Teva might in court say they used a certain process that does not infringe. Without replicating it, who is going to know that it would not work? Would some third party be allowed to have a go at that while the court twiddles its thumbs? Dunno.

Regards, RockRat